CRP and rheumatoid arthritis: The first line of treatment in RA are csDMARDs; a systematic review of 23 papers found that CRP > 7.1 mg/L was predictive of poor response to csDMARDs and CRP ≥ 3 mg/dL was predictive of bone erosion and cartilage destruction.